BioSpace News Archive

IGM Biosciences, Inc., a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on June 2, 2021 at 1:00 p.m. EDT.

Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system diseases, announced the appointment of Ms. Jiong Ma, PhD to its Board of Directors.

Athira Pharma, Inc. announced that Leen Kawas, Ph.D., President and Chief Executive Officer, will participate in a fireside chat and one-on-one investor meetings at the Jefferies Virtual Healthcare Conference to be held June 1-4, 2021 and the Goldman Sachs 42nd Annual Global Healthcare Conference to be held June 8-11, 2021.

Phase 3 GENESIS study in stem-cell mobilization (SCM) demonstrated highly statistically significant positive results across all primary and secondary endpoints

Valeo Pharma Inc., a Canadian pharmaceutical company, provided an outlook for its second quarter ended April 30th, projecting record revenues and margins.

PYC Therapeutics, a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of patients with inherited diseases, announced it will participate as one of a select group of companies at the upcoming Evercore ISI GenomeRx Emerging Therapeutic Company Day, taking place virtually on June 3.

Nuvation Bio Inc., a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, announced that David Hung, M.D., founder and chief executive officer of Nuvation Bio, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021, at 9:00 a.m. ET.

Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, announced that Andrew Robbins, Chief Executive Officer and President, will present at Jefferies Virtual Healthcare Conference on Thursday, June 3rd, from 11:30-11:55am ET.

MYND Life Sciences Inc. a life sciences company focused on novel psychedelic drug development and pharmaceuticals, is pleased to announce its shares have been approved for listing on the Canadian Securities Exchange. The Company’s shares will commence trading at market open on May 26, 2021

Both deeply experienced in working with advanced life sciences technology, David Bennett joins as VP Commercial Operations and Sandra Bläser as VP of Customer Success, to satisfy strong demand for Eagle Genomics’ microbiome discovery platform as global brands strive to create sustainable next-gen products